Daewoong
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Phar… Read more
Market Cap & Net Worth: Daewoong (003090)
Daewoong (KO:003090) has a market capitalization of $674.44 Million (₩987.51 Billion) as of March 19, 2026. Listed on the KO stock exchange, this Korea-based company holds position #13711 globally and #370 in its home market, demonstrating a 9.28% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daewoong's stock price ₩24150.00 by its total outstanding shares 40890710 (40.89 Million).
Daewoong Market Cap History: 2015 to 2026
Daewoong's market capitalization history from 2015 to 2026. Data shows growth from $303.47 Million to $675.83 Million (7.21% CAGR).
Daewoong Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daewoong's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Daewoong's market cap is 0.00 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
Daewoong's market cap is 0.01 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $303.47 Million | $996.76 Billion | $38.62 Billion | 0.00x | 0.01x |
| 2016 | $238.87 Million | $1.02 Trillion | $19.83 Billion | 0.00x | 0.01x |
| 2017 | $527.63 Million | $1.12 Trillion | $66.25 Billion | 0.00x | 0.01x |
| 2018 | $488.26 Million | $1.23 Trillion | $29.86 Billion | 0.00x | 0.02x |
| 2019 | $358.03 Million | $1.37 Trillion | $62.44 Billion | 0.00x | 0.01x |
| 2020 | $1.39 Billion | $1.36 Trillion | $98.38 Billion | 0.00x | 0.01x |
| 2021 | $862.98 Million | $1.51 Trillion | $78.81 Billion | 0.00x | 0.01x |
| 2022 | $568.31 Million | $1.70 Trillion | $102.57 Billion | 0.00x | 0.01x |
| 2023 | $576.69 Million | $1.81 Trillion | $152.67 Billion | 0.00x | 0.00x |
| 2024 | $603.22 Million | $1.94 Trillion | $57.89 Billion | 0.00x | 0.01x |
Competitor Companies of 003090 by Market Capitalization
Companies near Daewoong in the global market cap rankings as of March 19, 2026.
Key companies related to Daewoong by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Daewoong Historical Marketcap From 2015 to 2026
Between 2015 and today, Daewoong's market cap moved from $303.47 Million to $ 675.83 Million, with a yearly change of 7.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩675.83 Million | +9.75% |
| 2025 | ₩615.79 Million | +2.08% |
| 2024 | ₩603.22 Million | +4.60% |
| 2023 | ₩576.69 Million | +1.47% |
| 2022 | ₩568.31 Million | -34.15% |
| 2021 | ₩862.98 Million | -38.08% |
| 2020 | ₩1.39 Billion | +289.24% |
| 2019 | ₩358.03 Million | -26.67% |
| 2018 | ₩488.26 Million | -7.46% |
| 2017 | ₩527.63 Million | +120.88% |
| 2016 | ₩238.87 Million | -21.28% |
| 2015 | ₩303.47 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Daewoong was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $674.44 Million USD |
| MoneyControl | $674.44 Million USD |
| MarketWatch | $674.44 Million USD |
| marketcap.company | $674.44 Million USD |
| Reuters | $674.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.